VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AXGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AXGNAxoGen, Inc.
$55.38$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAXGNBalance Sheet

AxoGen, Inc. (AXGN) Balance Sheet

30Y historyFree accessUpdated daily

Total debt has fallen to $19.5M against $496.1M of equity and a 0.04 debt-to-equity ratio, while the current ratio of 12.02 and $328.9M cash position suggest a liquidity buffer that is no longer constrained, though the accumulated deficit of roughly -$325.7M warrants continued attention.

Income StatementBalance SheetCash FlowRatios

AXGN Balance Sheet

Annual statement

AXGN Balance Sheet

AxoGen, Inc. (AXGN) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Total Current Assets438.09M120.42M99.22M88M98.08M127.05M145.25M135.02M150.95M55.74M44.04M35.05M14.41M25.66M18.3M10.88M10.09M16.77M454.26K996.23K1.35M1.59M2.57M2M2.11M3.79M5.24M4.7M6.2M6.9M5.4M
Cash & Short-Term Investments348.07M35.55M33.48M31.02M48.79M84.09M103.97M96.51M116.61M36.51M30.01M25.91M8.22M20.07M13.91M8.19M7.08M15.77M332.85K832.92K1.28M1.31M2.24M483.84K671.59K1.43M100.17K01M700K800K
Cash Only328.89M35.55M27.55M31.02M15.28M32.76M48.77M35.72M24.29M36.51M30.01M25.91M8.22M20.07M13.91M8.19M7.08M15.77M332.85K832.92K1.28M1.31M2.24M483.84K671.59K1.43M100.17K01M700K800K
Short-Term Investments19.18M05.93M033.51M51.33M55.2M60.79M92.31M0000000000000000000000
Accounts Receivable34.01M26.17M24.11M25.15M22.19M18.16M17.62M16.94M15.32M11.06M8.05M4.78M2.87M1.89M1.05M797.65K407.35K31.52K32.59K100.43K0214.91K0203.87K318.9K547.84K1.58M2M2.7M2.3M2.1M
Days Sales Outstanding41.9242.4146.9757.7258.4352.0457.2657.9666.6266.8471.563.8862.3463.1449.8360.041.63K0.46163.58365-176.93-10.2816.9912.5539.4659.3576.468.2558.51
Inventory49.06M42.37M33.18M23.02M18.91M16.69M12.53M13.86M11.98M7.32M5.46M3.93M3.21M3.4M3.15M1.76M1.01M0000001.09M1.01M1.53M2.25M2.1M1.9M2.6M2M
Days Inventory Outstanding244.69267.33267.01226.21231.75265.71211.9291.62338.42286.77308.09296.16340.76508.41586.25264.82-------72.6370.7853.0795.7610582.56137.54104.29
Other Current Assets2M16.33M8.45M6M6.25M6.25M6.84M6M6M853.38K511.8K424.93K109.37K296.72K187.26K133.5K1.08M00000192.63K634.22K003.28M600K600K1M500K
Total Non-Current Assets112.25M101.27M104.51M108.82M97.31M80.97M56.13M19.62M9.22M3.13M2.32M2.49M1.99M2.03M1.93M1.61M56.31K35.38K69.99K103.76K166.59K232.61K233.21K688.66K2.04M2.56M3.24M4.1M4.4M4.9M6.9M
Property, Plant & Equipment95.34M94.52M98.93M104.29M93.66M78.12M54.08M18.11M8.04M2.2M1.49M970.87K619.03K381.69K108.53K247.82K3.65K5.57K5.93K0000477.06K1.75M2.26M3.04M3.9M4.1M4.6M5.1M
Fixed Asset Turnover2.79x2.38x1.89x1.52x1.48x1.63x2.08x5.89x10.44x27.50x27.51x28.15x27.17x28.68x70.87x19.57x25.02x4473.22x12.26x----15.17x3.91x7.04x4.80x3.15x3.15x2.67x2.57x
Goodwill000000000000000169.99K000000000000000
Intangible Assets7.91M6.75M5.58M4.53M3.65M2.86M2.05M1.51M1.18M936.99K828.98K678.08K577.17K570.4K573.73K899.48K52.66K29.81K43.77K42.92K65.19K90.65K50.69K211.59K285.86K297.07K199.35K200K300K400K600K
Long-Term Investments0000000000000000000000000000000
Other Non-Current Assets9M0000000000845.73K793.5K1.07M1.25M295.28K0-474K20.28K-4.62M101.4K141.96K182.51K000000-100K1.2M
Total Assets550.34M221.69M203.73M196.83M195.39M208.02M201.38M154.64M160.17M58.87M46.36M37.55M16.4M27.68M20.23M12.5M10.14M16.81M524.24K1.1M1.51M1.82M2.8M2.69M4.15M6.35M8.47M8.8M10.6M11.8M12.3M
Asset Turnover0.78x1.02x0.92x0.81x0.71x0.61x0.56x0.69x0.52x1.03x0.89x0.73x1.03x0.40x0.38x0.39x0.01x1.48x0.14x0.09x0.08x0.24x0.38x2.69x1.65x2.51x1.72x1.40x1.22x1.04x1.07x
Asset Growth %259.09%8.82%3.51%0.74%-6.07%3.3%30.22%-3.45%172.06%26.99%23.48%128.93%-40.76%36.84%61.91%23.18%-39.65%3106.23%-52.34%-27.38%-17%-34.9%4.18%-35.17%-34.64%-25.07%-3.7%-16.98%-10.17%-4.06%-3.15%
Total Current Liabilities36.46M23.56M30.61M30.43M23.75M24.29M22.83M20.88M13.04M13.72M11.08M3.71M2.45M2.1M1.48M2.02M114.35K5.75M211.06K201.17K217.87K160.86K521.05K2.78M3.17M2.68M3.72M2.5M2M2.8M1.2M
Accounts Payable34.63M2.89M8.01M11.77M8.96M5.92M4.6M8.26M4.52M3.24M3.61M2.11M1.16M1.18M1.22M1.59M62.3K84.66K26.16K13.41K14.48K10.49K4.94K19.8K587.65K628.36K1.18M1.7M1.5M800K800K
Days Payables Outstanding118.918.2264.44115.7109.8994.2877.75173.82127.58126.92203.97158.55123.09176.74227.1238.43-------1.3241.1521.8350.18565.1842.3241.71
Short-Term Debt00000001.74M28K735.02K4.05M0000434.73K0000002.52K12.56K1.15M938.8K860.1K0000
Deferred Revenue (Current)000000014K18K31.67K33.28K14.12K14.12K14.12K0-1.59M000000240.29K502.38K780.51K1.04M00000
Other Current Liabilities016.63M18.58M009.67M13.59M7.62M2M7.94M-804.69K000009.27M48K130K130K130K98.35K273.29K2.61M650.07K75K229.44K800K500K2M400K
Current Ratio12.02x5.11x3.24x2.89x4.13x5.23x6.36x6.47x11.57x4.06x3.97x9.45x5.89x12.23x12.36x5.39x88.21x2.92x2.15x4.95x6.19x9.90x4.93x0.72x0.67x1.41x1.41x1.88x3.10x2.46x4.50x
Quick Ratio10.67x3.31x2.16x2.14x3.33x4.54x5.81x5.80x10.65x3.53x3.48x8.39x4.58x10.61x10.23x4.52x79.39x2.92x2.15x4.95x6.19x9.90x4.93x0.33x0.35x0.84x0.80x1.04x2.15x1.54x2.83x
Cash Conversion Cycle167.71291.52249.54168.24180.3223.47191.42175.75277.47226.69175.62201.49280.01394.81408.9886.43-------81.646.6243.7985.1279.3593.78163.47121.08
Total Non-Current Liabilities17.78M69.28M69.21M70.73M70.64M71.18M55.4M1.61M147K19.97M20.36M25.64M25.2M25.45M21.58M4.4M62.3K84.66K26.16K13.41K14.48K10.49K7.47K62.44K10.77K125.17K31.18K200K200K200K200K
Long-Term Debt048.39M47.5M46.6M45.71M44.82M32.03M1.59M35K19.91M20.27M24.7M25.09M25.36M21.58M4.4M000000062.44K10.77K125.17K31.18K0000
Capital Lease Obligations34.51M16.87M19.22M21.14M20.41M20.8M20.87M1.59M00000000000000000000000
Deferred Tax Liabilities000000000-164K-92.22K-25.55M-25.09M-570.82K000-48K000000000200K200K200K200K
Other Non-Current Liabilities141K4.03M2.49M2.99M4.52M5.56M2.5M-1.59M70K000000062.3K00000000000000
Total Liabilities54.24M92.84M99.82M101.16M94.39M95.47M78.23M22.49M13.19M33.69M31.44M29.35M27.65M27.55M23.06M6.42M114.35K5.75M211.06K201.17K217.87K160.86K521.05K2.84M3.18M2.81M3.75M2.7M2.2M3M1.4M
Total Debt19.47M67.63M68.69M69.29M67.43M67.45M53.76M4.93M63K24.64M24.31M25.55M25.09M25.36M21.58M4.84M8.4M000002.52K295K1.17M1.06M891.29K0000
Net Debt-309.42M32.08M41.13M38.27M52.14M34.7M5M-30.8M-24.23M-11.87M-5.7M-362.08K16.87M5.29M7.67M-3.35M1.32M-15.77M-332.85K-832.92K-1.28M-1.31M-2.24M-188.84K493.59K-361.24K791.12K0-1M-700K-800K
Debt / Equity0.04x0.52x0.66x0.72x0.67x0.60x0.44x0.04x0.00x0.98x1.63x3.12x-185.63x-0.80x0.84x-----0.00x-1.21x0.30x0.19x----
Debt / EBITDA-3.98x196.60x15.10x-------------------0.03x--------
Net Debt / EBITDA63.21x93.26x9.04x---------------0.99x-----25.51x------2.50x-0.64x-1.60x
Interest Coverage-12.49x-1.04x-0.21x-6.66x-45.39x-18.90x-21.57x-727.38x-17.54x-3.24x-1.30x-2.24x-1.24x-1.91x-3.27x-2.98x-2.10x-------42.74x-19.01x-0.88x----0.18x-
Total Equity496.1M128.85M103.91M95.67M101M112.55M123.15M132.15M146.98M25.18M14.92M8.2M-11.25M136.63K-2.83M6.07M10.03M11.06M313.19K898.82K1.3M1.66M2.28M-153.77K966.8K3.54M4.72M6.1M8.4M8.8M10.9M
Equity Growth %595.25%24%8.62%-5.28%-10.26%-8.61%-6.81%-10.09%483.68%68.77%82.06%172.88%-8330.57%104.83%-146.6%-39.46%-9.33%3431.81%-65.16%-30.69%-22.07%-27.09%1584.11%-115.9%-72.69%-24.99%-22.63%-27.38%-4.55%-19.27%-2.68%
Book Value per Share8.062.802.352.232.402.733.083.373.960.760.490.31-0.630.01-0.261.642.332.570.070.220.310.400.55-0.040.240.901.211.542.102.282.87
Total Shareholders' Equity496.1M128.85M103.91M95.67M101M112.55M123.15M132.15M146.98M25.18M14.92M8.2M-11.25M136.63K-2.83M6.07M10.03M11.06M313.19K898.82K1.3M1.66M2.28M-153.77K966.8K3.54M4.72M6.1M8.4M8.8M10.9M
Common Stock597K472K441K431K424K417K406K396K389K343.5K330.09K299.85K194.89K173.4K111.23K110.62K43.05K42.9K42.9K41.76K41.49K41.49K40.3K39.79K39.66K39.41K39.05K0000
Retained Earnings-325.73M-306.96M-291.26M-281.3M-259.58M-230.63M-203.65M-179.86M-150.73M-128.33M-117.88M-103.47M-90.12M-72.41M-57.85M-48.43M-2.95M-1.63M-12.38M-11.34M-10.59M-10.23M-9.45M-11.74M-10.46M-7.86M-6.64M-5.2M-2.9M-1.7M600K
Treasury Stock0000000000000000000000000000000
Accumulated OCI00000000-2.86M-2.29M-1.8M-1.94M-1.74M-1.58M-1.5M-1.32M-6.2K-3.02K-7010000-4.85M-5.43M04.84K-6M-5.3M-4.2M-3.5M
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Accumulated deficit persists

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Balance Sheet Strengthens Through Capital Inflows

According to reported quarterly figures, AXGN's total assets expanded from $188.9M in 2024Q2 to $550.3M in 2026Q3, with cash rising to $328.9M, suggesting the balance sheet has strengthened substantially over the period under review.

The jump in cash from roughly $94.6M to $328.9M between 2026Q2 and 2026Q3 appears to reflect a large external capital event or equity-related inflow rather than organic operating accumulation, given that operating profitability remains thin. Equity grew from $95.7M to $496.1M over the same window, which suggests that the strengthening is driven primarily by financing rather than retained earnings. Investors should monitor whether this liquidity is deployed productively or whether it simply funds continued losses.

Leverage Minimal Following Debt Stabilization

Based on AXGN's reported figures, total debt has held near $20M since 2026Q1 after exceeding $68M through 2025, reducing the debt-to-equity ratio from 0.52 to 0.04 in the latest quarter.

The reduction in debt from roughly $67.6M to $19.5M suggests a deliberate deleveraging step, likely funded by the recent equity-related cash inflow rather than operating cash flow. A D/E ratio of 0.04 indicates that financial leverage is no longer a meaningful constraint on the equity thesis. The remaining debt load warrants modest monitoring for its covenant terms and maturity profile, which are not provided in the supplied data.

Liquidity Buffer Expands Sharply Post-Raise

As reported in financial statements, AXGN's current ratio climbed to 12.02 in 2026Q3 from 5.11 at year-end 2025, reflecting a cash position of $328.9M against liabilities of just $54.2M.

A current ratio above 12 signals an exceptionally large short-term asset cushion relative to obligations, which provides substantial runway against operating shocks. The cash balance of $328.9M is large relative to the company's recent quarterly operating cash outflows and capital needs, reducing near-term funding risk. The more relevant question is whether management will sustain this buffer as it scales commercial operations and funds the BLA pathway.

Asset Base Dominated by Liquid Holdings

Based on EDBL's reported figures, AXGN's goodwill of $7.9M and net PP&E of $95.3M together represent a small share of the $550.3M asset base, indicating that the balance sheet is no longer driven by intangible or fixed-asset concentration.

Goodwill remains modest and stable, implying limited impairment exposure relative to the overall asset base. Net PP&E has been broadly flat near $95M to $100M over the observed period, which suggests the Alachua facility investment is largely captured within a stable fixed-asset line rather than generating visible step-ups. The asset composition therefore reflects a cash-heavy structure, which tilts the risk profile toward how that cash is ultimately deployed.

Accumulated Deficit Limits Equity Quality

As reported in financial statements, AXGN's retained earnings remain near -$325.7M, meaning that the reported equity of $496.1M is largely built from contributed capital rather than cumulative profitability.

A persistent accumulated deficit of this magnitude indicates that the company has not yet generated sustainable cumulative earnings, and the headline equity figure reflects capital raised rather than value created internally. Stock-based compensation and ongoing dilution may further erode per-share economics over time, which the balance sheet alone cannot fully capture. Investors should treat the strong book equity as a function of financing history and evaluate it alongside share count trends.

AXGN — Frequently Asked Questions

Quick answers to the most common questions about buying AXGN stock.

What are the total assets of AxoGen, Inc. (AXGN)?

As of 2025, AxoGen, Inc. (AXGN) had total assets of $221.7M including $120.4M in current assets.

How much debt does AxoGen, Inc. (AXGN) have?

AxoGen, Inc. (AXGN) carries total debt of $67.6M, offset by $35.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of AxoGen, Inc.?

AxoGen, Inc. (AXGN) has total shareholders' equity (book value) of $128.8M ($2.80 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is AxoGen, Inc.'s current ratio and liquidity?

AxoGen, Inc. (AXGN) reported a current ratio of 5.11x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.